Kwangdong Healthbio Co., Ltd. (XKON:086220)
South Korea · Delayed Price · Currency is KRW 1,468.00
-32.00 (-2.13%)
At close: Aug 1, 2025, 3:30 PM KST
Kwangdong Healthbio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | 2005 - 2009 |
|---|---|---|---|---|---|---|
Period Ending | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | 2005 - 2009 |
Net Income | -323.52 | -380.7 | 466.04 | 830.38 | -1,822 | Upgrade |
Depreciation & Amortization | 1,629 | 1,601 | 1,559 | 1,324 | 1,131 | Upgrade |
Other Amortization | - | - | - | - | 1.33 | Upgrade |
Loss (Gain) From Sale of Assets | 7.4 | -3.68 | -19.22 | 0.46 | -9.27 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | 2,109 | Upgrade |
Loss (Gain) From Sale of Investments | 182.53 | 60 | - | - | - | Upgrade |
Provision & Write-off of Bad Debts | 195.16 | 798.55 | 24.32 | 0.83 | 1,812 | Upgrade |
Other Operating Activities | 208.05 | 1,513 | 406.18 | 211.05 | 425.15 | Upgrade |
Change in Accounts Receivable | 1,754 | -3,417 | 159.07 | -161.1 | -1,622 | Upgrade |
Change in Inventory | -1,497 | 448.95 | -1,746 | -867.28 | -1,352 | Upgrade |
Change in Accounts Payable | 240.57 | 442.48 | -925.85 | -1,986 | 1,550 | Upgrade |
Change in Income Taxes | - | - | - | 74.55 | - | Upgrade |
Change in Other Net Operating Assets | -1,813 | 1,416 | 89.18 | 1,541 | 1,799 | Upgrade |
Operating Cash Flow | 583.5 | 2,479 | 12.33 | 923.5 | 3,289 | Upgrade |
Operating Cash Flow Growth | -76.46% | 20005.03% | -98.67% | -71.92% | 79.89% | Upgrade |
Capital Expenditures | -233.24 | -625.33 | -857.07 | -6,941 | -659.56 | Upgrade |
Sale of Property, Plant & Equipment | 8.36 | 9.55 | 130.3 | 80.18 | 34.98 | Upgrade |
Sale (Purchase) of Intangibles | -3.22 | -41.3 | -157.55 | -418.36 | -441.92 | Upgrade |
Investment in Securities | -154.32 | -268.2 | 381.36 | 1,795 | -790.53 | Upgrade |
Other Investing Activities | -10 | - | - | - | - | Upgrade |
Investing Cash Flow | -392.41 | -925.28 | -502.96 | -5,485 | -1,857 | Upgrade |
Short-Term Debt Issued | 6,451 | 21,396 | 3,675 | 3,466 | 3,886 | Upgrade |
Long-Term Debt Issued | - | 994 | - | 1,124 | - | Upgrade |
Total Debt Issued | 6,451 | 22,390 | 3,675 | 4,590 | 3,886 | Upgrade |
Short-Term Debt Repaid | -13,922 | -23,839 | - | - | - | Upgrade |
Long-Term Debt Repaid | -124.26 | - | -3,308 | - | -5,342 | Upgrade |
Total Debt Repaid | -14,046 | -23,839 | -3,308 | - | -5,342 | Upgrade |
Net Debt Issued (Repaid) | -7,595 | -1,449 | 367.18 | 4,590 | -1,456 | Upgrade |
Issuance of Common Stock | 8,424 | - | - | - | - | Upgrade |
Repurchase of Common Stock | - | - | -0.19 | - | - | Upgrade |
Other Financing Activities | - | - | 0 | - | - | Upgrade |
Financing Cash Flow | 828.29 | -1,449 | 366.99 | 4,590 | -1,456 | Upgrade |
Foreign Exchange Rate Adjustments | 0.24 | -0.58 | - | - | - | Upgrade |
Miscellaneous Cash Flow Adjustments | -0 | -0 | -0 | - | -0 | Upgrade |
Net Cash Flow | 1,020 | 104.51 | -123.64 | 29.26 | -23.85 | Upgrade |
Free Cash Flow | 350.26 | 1,854 | -844.74 | -6,018 | 2,630 | Upgrade |
Free Cash Flow Growth | -81.11% | - | - | - | 79.96% | Upgrade |
Free Cash Flow Margin | 0.92% | 5.83% | -2.36% | -20.18% | 5.61% | Upgrade |
Free Cash Flow Per Share | 61.71 | 336.00 | -117.82 | -710.23 | 311.76 | Upgrade |
Cash Interest Paid | 1,709 | 1,422 | 1,871 | 2,374 | 1,598 | Upgrade |
Cash Income Tax Paid | 450.29 | 48.38 | 113.57 | - | - | Upgrade |
Levered Free Cash Flow | 954.72 | 2,011 | 10,410 | -5,242 | 77.99 | Upgrade |
Unlevered Free Cash Flow | 1,553 | 2,806 | 11,710 | -4,012 | 1,433 | Upgrade |
Change in Net Working Capital | 480.73 | -1,345 | -10,105 | -314.72 | -260.27 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.